Structure Therapeutics Inc. (GPCR) SEC filings
GPCR SEC filings moved a median of -1.78% by the close. GPCR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GPCR overview →
56 measured GPCR SEC filing events.
Where these GPCR SEC filings landedvs 56 measured GPCR SEC filing reactions
| Middle 50% of GPCR SEC filing reactions | -3.39% to +1.33% |
|---|---|
| Median reaction (to close) | -1.78% |
| Measured reactions | 56 |
Point-in-time · zero look-ahead
Half of the 56 GPCR SEC filing events with a measured close landed between -3.39% and +1.33%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Structure Therapeutics For: Sep 08 | SEC filing · Form 8-K | -4.78% | -13.79% | |
| Form 10-Q Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.99% | -1.45% | |
| Form 8-K Structure Therapeutics For: Aug 06 | SEC filing · Form 8-K | -0.99% | -1.45% | |
| Form 8-K Structure Therapeutics For: Jun 17 | SEC filing · Form 8-K | +3.12% | +2.27% | |
| Form 10-Q Structure Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.54% | +2.46% | |
| Form 8-K Structure Therapeutics For: May 07 | SEC filing · Form 8-K | +2.54% | +2.46% | |
| Form ARS Structure Therapeutics For: Dec 31 | SEC filing · Form ARS | -0.01% | -3.21% | |
| Form DEF 14A Structure Therapeutics For: Jun 17 | SEC filing · Form DEF | -0.01% | -3.21% | |
| Form 8-K Structure Therapeutics For: Apr 15 | SEC filing · Form 8-K | -0.01% | +2.86% | |
| Form 8-K Structure Therapeutics For: Mar 16 | SEC filing · Form 8-K | -2.26% | +0.12% | |
| Form 10-K Structure Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.97% | -1.79% | |
| Form 8-K Structure Therapeutics For: Feb 26 | SEC filing · Form 8-K | +0.97% | -1.79% | |
| Form S-8 Structure Therapeutics | SEC filing · Form S-8 | +0.97% | -1.79% | |
| Form 8-K Structure Therapeutics For: Dec 30 | SEC filing · Form 8-K | +0.79% | -0.25% | |
| Form 8-K Structure Therapeutics For: Dec 09 | SEC filing · Form 8-K | +1.29% | -2.68% | |
| Form 8-K Structure Therapeutics For: Dec 08 | SEC filing · Form 8-K | +17.11% | +54.93% | |
| Form 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -1.22% | -2.55% | |
| Form 8-K Structure Therapeutics For: Nov 06 | SEC filing · Form 8-K | -1.22% | -2.55% | |
| Form 10-Q Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -2.37% | -8.42% | |
| Form 8-K Structure Therapeutics For: Aug 06 | SEC filing · Form 8-K | -2.37% | -8.42% | |
| Form S-3ASR Structure Therapeutics | SEC filing · Form S-3ASR | -2.37% | -8.42% | |
| Form 8-K Structure Therapeutics For: Jun 23 | SEC filing · Form 8-K | +0.67% | -2.99% | |
| Form 10-Q Structure Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -0.30% | -4.05% | |
| Form 8-K Structure Therapeutics For: May 08 | SEC filing · Form 8-K | -0.30% | -4.05% | |
| Form ARS Structure Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.60% | +1.02% | |
| Form DEF 14A Structure Therapeutics For: Jun 23 | SEC filing · Form DEF | +0.60% | +1.02% | |
| Form 10-K Structure Therapeutics For: Dec 31 | SEC filing · Form 10-K | -0.26% | +2.37% | |
| Form 8-K Structure Therapeutics For: Feb 27 | SEC filing · Form 8-K | -0.26% | +2.37% | |
| Form S-8 Structure Therapeutics | SEC filing · Form S-8 | -0.26% | +2.37% | |
| Form 8-K Structure Therapeutics For: Dec 17 | SEC filing · Form 8-K | -5.44% | -5.74% | |
| Form 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -3.79% | +4.69% | |
| Form 8-K Structure Therapeutics For: Nov 13 | SEC filing · Form 8-K | -3.79% | +4.69% | |
| Form 8-K Structure Therapeutics For: Sep 12 | SEC filing · Form 8-K | -0.37% | +0.05% | |
| Form 8-K Structure Therapeutics For: Aug 24 | SEC filing · Form 8-K | +0.00% | -4.26% | |
| Form 10-Q Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -4.03% | -6.12% | |
| Form 8-K Structure Therapeutics For: Aug 08 | SEC filing · Form 8-K | -4.03% | -6.12% | |
| Form 8-K Structure Therapeutics For: Jun 25 | SEC filing · Form 8-K | -3.45% | +0.41% | |
| Form EFFECT Structure Therapeutics | SEC filing · Form EFFECT | -0.49% | -1.77% | |
| Form S-1MEF Structure Therapeutics | SEC filing · Form S-1MEF | -0.49% | -1.77% | |
| Form 8-K Structure Therapeutics For: Jun 03 | SEC filing · Form 8-K | -1.71% | +48.77% | |
| Form S-1 Structure Therapeutics | SEC filing · Form S-1 | -5.02% | -3.91% | |
| Form 10-Q Structure Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.38% | -2.98% | |
| Form 8-K Structure Therapeutics For: May 09 | SEC filing · Form 8-K | +2.38% | -2.98% | |
| Form ARS Structure Therapeutics For: Dec 31 | SEC filing · Form ARS | -2.41% | -0.20% | |
| Form DEF 14A Structure Therapeutics For: Jun 25 | SEC filing · Form DEF | -2.41% | -0.20% | |
| Form 10-K Structure Therapeutics For: Dec 31 | SEC filing · Form 10-K | -0.04% | +0.19% | |
| Form 8-K Structure Therapeutics For: Mar 08 | SEC filing · Form 8-K | -0.04% | +0.19% | |
| Form S-8 Structure Therapeutics | SEC filing · Form S-8 | -2.32% | -6.55% | |
| Form 8-K Structure Therapeutics For: Dec 18 | SEC filing · Form 8-K | -13.52% | +5.72% | |
| Form EFFECT Structure Therapeutics | SEC filing · Form EFFECT | -1.16% | +4.25% | |
| Form 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.51% | -2.21% | |
| Form 10-Q/A Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.51% | -2.21% | |
| Form S-1 Structure Therapeutics | SEC filing · Form S-1 | +0.51% | -2.21% | |
| Form 10-Q/A Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +4.48% | +14.97% | |
| Form 8-K Structure Therapeutics For: Nov 07 | SEC filing · Form 8-K | +0.95% | -10.67% | |
| Form NT 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form NT | +0.95% | -10.67% |
Keep exploring
More GPCR: earnings → · analyst actions → · GPCR overview →